Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nutra Pharma widens homeopathic pain reliever distribution

This article was originally published in The Tan Sheet

Executive Summary

The Plantation, Fla.-based manufacturer will register its new homeopathic pain reliever Cobroxin for over-the-counter sales in Canada and Europe, according to a Sept. 21 release. NutraPharma claims Cobroxin is the first OTC product to treat moderate to severe chronic pain. The cobra venom-based oral spray and topical gel launched in the U.S. in August and will be available in drugstores soon, according to its Web site. XenaCare Holding has the exclusive U.S. marketing and distribution rights for Cobroxin
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS103371

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel